202825-45-4
202825-45-4
Chemical Structure
Ralfinamide mesylate
Synonym(s): FCE-26742A mesylate
- CAS No.: 202825-45-4
- Formula:C18H23FN2O5S
- Molecular Weight:398.45
IUPAC Name: (S)-2-((4-((2-fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate
InChIKey: CHQVNINIGBRKGZ-YDALLXLXSA-N
SMILES: C[C@H](NCC1=CC=C(OCC2=CC=CC=C2F)C=C1)C(N)=O.CS(=O)(O)=O
Biological Activity: Ralfinamide mesylate (FCE-26742A mesylate) is an orally available Na+ channel blocker derived from α-aminoamide, with function of suppressing pain[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ralfinamide mesylate | 99.41% | Ralfinamide mesylate (FCE-26742A mesylate) is an orally available Na+ channel blocker derived from α-aminoamide, with function of suppressing pain. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Zhang SH, et al. Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long-lasting suppression of spontaneous neuropathic pain-related behavior in the rat. Pain. 2008 Oct 15;139(2):293-305. [Content Brief]
- [2]. Liang X, et al. Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain. Eur J Pharmacol. 2018 Mar 15;823:27-34. [Content Brief]
